跳至主要内容
临床试验/CTRI/2018/06/014635
CTRI/2018/06/014635尚未招募2 期

A Comparative Study on Asanadi Yoga with Shalvarga and Metformin on Sthula Madhumeha with special reference to Type 2 Diabetes Mellitus specifically on HbA1c and Lipid Profile

Shweta Ramesh Aswar0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patient having fasting plasma glucose level 126mg/dl to 200mg/dl and post prandial plasma glucose level 200mg/dl to250mg/dl.
  • 2.HbA1c is 6.5% up to 8.5%. (In standardised assay, the HbA1c approximates the estimated average glucose value according to ADAG formula (A1c Derivated
  • Average Glucose Level) that is 140mg/dl to197mg/dl[29]
  • 3.Patients fulfilling criteria of diagnosis and having clinical features of Sthula
  • Madhumeha (Diabetes Mellitus)
  • 4.Patients having BMI more than 23Kg/m2 up to 30Kg/m2 will be selected.
  • 5.Those are willing to participate in trial and ready to give written consent.
  • 6.Patients with controlled Hypertension.

排除标准

  • 1.Patients who already taken anti Diabetic drugs.
  • 2.Patients having Insulin Dependent Diabetes Mellitus and Juvenile Diabetes and various other types of Diabetes except Type II DM
  • 3.Patients having complications such as vasculopathy, nephropathy, retinopathy and neuropathy.
  • 4.Patients having other systemic complications like hepatic, renal and cardiac problems.
  • 5.Pregnant and lactating females not included in this study.
  • 6.Patients who are currently participating in any other clinical trials since last 6 months.

研究者

发起方
Shweta Ramesh Aswar

相似试验